Information
62 Yonggu-daero 2325beon-gil, Giheung-gu, Yongin-si, Gyeonggi-do, South Korea
+82 2-3463-7707
-
-
Overview
- Summary
- SOOIL Development is a specialized medical device company that develops, manufactures, and sells insulin pumps, infusion sets, and related accessories for diabetic patients. The company holds a pioneering position in diabetes treatment, having successfully commercialized the world's first insulin pump. It is an innovative technology company that is transforming the paradigm of diabetes management through the development of AI-based Automated Insulin Delivery (AID) systems.SOOIL Development is a specialized medical device company that develops, manufactures, and sells insulin pumps, infusion sets, and related accessories for diabetic patients. The company holds a pioneering position in diabetes treatment, having successfully commercialized the world's first insulin pump. It is an innovative technology company that is transforming the paradigm of diabetes management through the development of AI-based Automated Insulin Delivery (AID) systems.
- Key Products/Technologies
- **Insulin Pumps**: Models include Diabecare DANA-i, DANA Diabecare IIS, DANA Diabecare R, and DANA Diabecare RS. The DANA-i model features remote control via smartphone apps (Android/iOS), Secure BLE 5.0 communication, a 300-unit insulin reservoir, IP68 waterproof rating, and a lightweight design of 86g. The DANA R model offers an ultra-lightweight design of 63g, IPX8 waterproof rating, 300-unit capacity, and functions for PC data download and remote control. Basal rates are adjustable from 0.04 unit/hr in increments of 0.01 or 0.1 unit/hr, and boluses can be delivered in increments of 0.05, 0.1, 0.5, or 1.0 units.**Insulin Pumps**: Models include Diabecare DANA-i, DANA Diabecare IIS, DANA Diabecare R, and DANA Diabecare RS. The DANA-i model features remote control via smartphone apps (Android/iOS), Secure BLE 5.0 communication, a 300-unit insulin reservoir, IP68 waterproof rating, and a lightweight design of 86g. The DANA R model offers an ultra-lightweight design of 63g, IPX8 waterproof rating, 300-unit capacity, and functions for PC data download and remote control. Basal rates are adjustable from 0.04 unit/hr in increments of 0.01 or 0.1 unit/hr, and boluses can be delivered in increments of 0.05, 0.1, 0.5, or 1.0 units.
- **Automated Insulin Delivery (AID) System**: Development of a complete artificial pancreas system combining Continuous Glucose Monitoring (CGM) and Artificial Intelligence (AI) algorithms. Through collaboration with Diabeloop of France, the DBLG1 AID solution is being integrated with the Dana-i insulin pump, pursuing US FDA and European CE certifications. This system predicts blood glucose changes and automatically adjusts insulin dosage, contributing to hypoglycemia prevention and optimized blood glucose management.**Automated Insulin Delivery (AID) System**: Development of a complete artificial pancreas system combining Continuous Glucose Monitoring (CGM) and Artificial Intelligence (AI) algorithms. Through collaboration with Diabeloop of France, the DBLG1 AID solution is being integrated with the Dana-i insulin pump, pursuing US FDA and European CE certifications. This system predicts blood glucose changes and automatically adjusts insulin dosage, contributing to hypoglycemia prevention and optimized blood glucose management.
- **Infusion Sets and Accessories**: Provides a range of infusion sets and related accessories, including Soft Release O, Soft Release ST, Easy Release, Easy Release II, and Superline-ST.**Infusion Sets and Accessories**: Provides a range of infusion sets and related accessories, including Soft Release O, Soft Release ST, Easy Release, Easy Release II, and Superline-ST.
- **Mobile App**: The AnyDANA app enables real-time monitoring and control of insulin dosage, meal intake, exercise, and insulin delivery patterns via smartphone.**Mobile App**: The AnyDANA app enables real-time monitoring and control of insulin dosage, meal intake, exercise, and insulin delivery patterns via smartphone.
- Core Advantages
- **World's First Commercialization of Insulin Pump and Over 47 Years of Technology**: Established a pioneering position in diabetes treatment by developing the world's first portable insulin pump in 1979 and successfully commercializing it in 1980. Possesses over 47 years of history in insulin pump technology development and refinement.**World's First Commercialization of Insulin Pump and Over 47 Years of Technology**: Established a pioneering position in diabetes treatment by developing the world's first portable insulin pump in 1979 and successfully commercializing it in 1980. Possesses over 47 years of history in insulin pump technology development and refinement.
- **Global Market Leadership and Extensive Export Network**: Achieved global recognition for technology and quality by obtaining quality certifications in over 60 countries, including US FDA and European CE. Established a global distribution network, exporting insulin pumps to 66 countries worldwide, including Germany, France, the UK, Israel, and China.**Global Market Leadership and Extensive Export Network**: Achieved global recognition for technology and quality by obtaining quality certifications in over 60 countries, including US FDA and European CE. Established a global distribution network, exporting insulin pumps to 66 countries worldwide, including Germany, France, the UK, Israel, and China.
- **AI-based Automated Insulin Delivery (AID) System Technology**: Developed a next-generation artificial pancreas system integrating Continuous Glucose Monitoring (CGM) and AI algorithms through collaboration with Diabeloop of France. Maximizes blood glucose management efficiency and prevents hypoglycemia by predicting blood glucose changes and automatically adjusting insulin dosage.**AI-based Automated Insulin Delivery (AID) System Technology**: Developed a next-generation artificial pancreas system integrating Continuous Glucose Monitoring (CGM) and AI algorithms through collaboration with Diabeloop of France. Maximizes blood glucose management efficiency and prevents hypoglycemia by predicting blood glucose changes and automatically adjusting insulin dosage.
- **High Security and User Convenience**: The 'Dana Diabecare RS System' insulin pump received the highest 'Green' grade IoT security certification from the German Federal Office for Information Security (BSI). Obtained 'Basic' grade IoT security certification from the Korea Internet & Security Agency (KISA), proving the safety of its smart healthcare technology. Enhanced user convenience through remote control via smartphone apps and various customizable features.**High Security and User Convenience**: The 'Dana Diabecare RS System' insulin pump received the highest 'Green' grade IoT security certification from the German Federal Office for Information Security (BSI). Obtained 'Basic' grade IoT security certification from the Korea Internet & Security Agency (KISA), proving the safety of its smart healthcare technology. Enhanced user convenience through remote control via smartphone apps and various customizable features.
- **Continuous Research and Development Towards Artificial Pancreas**: Committed to continuous new product development with the goal of creating a complete artificial pancreas through the combination of cutting-edge medicine and ultra-precision engineering. Operates a biotechnology research institute and actively conducts clinical research through collaborations with leading Korean universities such as Seoul National University and Konkuk University.**Continuous Research and Development Towards Artificial Pancreas**: Committed to continuous new product development with the goal of creating a complete artificial pancreas through the combination of cutting-edge medicine and ultra-precision engineering. Operates a biotechnology research institute and actively conducts clinical research through collaborations with leading Korean universities such as Seoul National University and Konkuk University.
- Target Industrie
- Medical Device IndustryMedical Device Industry
- Diabetes Treatment and ManagementDiabetes Treatment and Management
- Smart HealthcareSmart Healthcare
- Major Markets
- MoroccoMorocco
- China, Indonesia, Singapore, IsraelChina, Indonesia, Singapore, Israel
- Germany, France, Italy, United Kingdom, Austria, Netherlands, BelgiumGermany, France, Italy, United Kingdom, Austria, Netherlands, Belgium
- United StatesUnited States
- Colombia, ChileColombia, Chile
- Certifications/Patents
- US Food and Drug Administration (FDA) approvalUS Food and Drug Administration (FDA) approval
- European CE Mark certificationEuropean CE Mark certification
- ISO 9001, ISO 13485 quality standard certificationsISO 9001, ISO 13485 quality standard certifications
- German Federal Office for Information Security (BSI) IoT security certification 'Green Grade' (DANA Diabecare RS System)German Federal Office for Information Security (BSI) IoT security certification 'Green Grade' (DANA Diabecare RS System)
- Korea Internet & Security Agency (KISA) IoT security certification 'Basic Grade' (DANA Diabecare R)Korea Internet & Security Agency (KISA) IoT security certification 'Basic Grade' (DANA Diabecare R)
- Over 57 domestic and international patents related to diabetes treatmentOver 57 domestic and international patents related to diabetes treatment
- Minister of Health and Welfare AwardMinister of Health and Welfare Award
- 7 Million Dollar Export Tower Award (2022)7 Million Dollar Export Tower Award (2022)
- Selected as a 'Global Hidden Champion' (2020)Selected as a 'Global Hidden Champion' (2020)
Introduction
Location
62 Yonggu-daero 2325beon-gil, Giheung-gu, Yongin-si, Gyeonggi-do, South Korea
클릭하여 위치 살펴보기
